Magnitude of Drug–Drug Interactions in Special Populations

Drug–drug interactions (DDIs) are one of the most frequent causes of adverse drug reactions or loss of treatment efficacy. The risk of DDIs increases with polypharmacy and is therefore of particular concern in individuals likely to present comorbidities (i.e., elderly or obese individuals). These sp...

Full description

Bibliographic Details
Main Authors: Sara Bettonte, Mattia Berton, Catia Marzolini
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/14/4/789

Similar Items